Clinical trials
Completed Phase 1 Dementia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 2 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 5 |
| 2021 | 2 |
| 2022 | 4 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| University of Kansas Medical Center | 3 |
| Siena Biotech S.p.A. | 2 |
| Stanford University | 2 |
| Tetra Discovery Partners | 2 |
| Texas Christian University | 2 |
| Abrexa Pharmaceuticals, Inc. | 1 |
| Alzinova AB | 1 |
| Axon Neuroscience SE | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 47 |
| Alzheimer Disease | 21 |
| Cognitive Dysfunction | 8 |
| Brain Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Neurodegenerative Diseases | 4 |
| Mental Disorders | 3 |
| Nervous System Diseases | 3 |
| Pick Disease of the Brain | 3 |
| Basal Ganglia Diseases | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.